Nuformix PLC NFX:London Stock Exchange

RT Quote | Exchange | GBp
Last | 03/27/24 GMT
0.19UNCH (UNCH)
52 week range
0.18 - 0.44
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.19
  • 52 Week High0.44
  • 52 Week High Date01/24/24
  • 52 Week Low0.18
  • 52 Week Low Date03/27/24

Key Stats

  • Market Cap1.79M
  • Shares Out744.31M
  • 10 Day Average Volume1.42M
  • Dividend-
  • Dividend Yield-
  • Beta2.07
  • YTD % Change-44.62

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.19
  • 52 Week High0.44
  • 52 Week High Date01/24/24
  • 52 Week Low0.18
  • 52 Week Low Date03/27/24
  • Market Cap1.79M
  • Shares Out744.31M
  • 10 Day Average Volume1.42M
  • Dividend-
  • Dividend Yield-
  • Beta2.07
  • YTD % Change-44.62

RATIOS/PROFITABILITY

  • EPS (TTM)-0.08
  • P/E (TTM)-2.38
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nuformix PLC

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Nuformix plc is a United Kingdom-based pharmaceutical development company. The Company is engaged in targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its clinical pipeline includes NXP001, NXP002, and NXP004. NXP002 is its pre-clinical lead asset and a potential inhaled treatment for idiopathic pulmonary fibrosis (IPF) and possibly other fibrosing interstitial lung diseases (ILDs). NXP001 is a form of the drug aprepitant that is marketed as a...
Address
6th Floor, 60 Gracechurch Street
London
EC3V 0HR
United Kingdom